Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy

BACKGROUND: Prior studies have evaluated the use of various constituents of cannabis for their anti-seizure effects. Specifically, cannabidiol, a non-psychoactive component of cannabis, has been investigated for treatment-resistant epilepsy, but more information is needed particularly on its use in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Drugs
Main Authors: Wheless, James W., Dlugos, Dennis, Miller, Ian, Oh, D. Alexander, Parikh, Neha, Phillips, Steven, Renfroe, J. Ben, Roberts, Colin M., Saeed, Isra, Sparagana, Steven P., Yu, Jin, Cilio, Maria Roberta
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2019
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534520/
https://ncbi.nlm.nih.gov/pubmed/31049885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-019-00624-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados